Results
20
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
20 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ORAD | ₪0.69 | 0.4% | 93.9% | ₪64.8m | n/a | PE8.5x | n/a | n/a | ||
SNCM | ₪1.08 | 1.6% | 10.2% | ₪233.7m | n/a | PE6.9x | n/a | 29.9% | ||
NXSN | ₪48.03 | 8.2% | 76.9% | ₪3.8b | n/a | PE17.2x | n/a | 1.4% | ||
ORTC | ₪9.56 | -6.8% | -34.8% | ₪42.7m | n/a | PS8.8x | n/a | 5.2% | ||
MCRNT | ₪1.73 | 2.9% | -7.4% | ₪16.2m | n/a | PS6.1x | n/a | 0% | ||
ECPA-M | ₪0.097 | 10.2% | -94.3% | ₪9.5m | n/a | PS0.8x | n/a | 1,718.2% | ||
UNIT | ₪29.35 | -4.5% | -6.5% | ₪409.2m | n/a | PE8x | n/a | 7.8% | ||
DNA | ₪0.75 | -7.2% | 25.3% | ₪92.1m | n/a | PE6.1x | n/a | n/a | ||
CLAB | ₪11.10 | 0.8% | -14.9% | ₪94.1m | n/a | PE6x | n/a | n/a | ||
SVRE | ₪0.053 | -15.9% | -82.7% | ₪6.3m | n/a | PS3.7x | E31.6% | n/a | ||
NYAX | ₪108.00 | -1.6% | 39.7% | ₪3.9b | ₪118.06 | PS3.6x | E122.3% | n/a | ||
PCBT | ₪6.31 | -14.0% | 91.5% | ₪452.3m | n/a | PE35.9x | n/a | 3.3% | ||
STG | ₪40.82 | -1.8% | 12.8% | ₪189.8m | n/a | PE10x | n/a | 0% | ||
TLSY | ₪183.70 | 1.5% | -25.4% | ₪1.6b | n/a | PE14.5x | n/a | 7.5% | ||
ININ | ₪2.56 | -0.8% | 16.1% | ₪111.8m | n/a | PS0.2x | n/a | 0% | ||
FGAS | ₪11.28 | 3.4% | 42.4% | ₪237.0m | n/a | PS6.9x | n/a | n/a | ||
ACCL | ₪1.37 | 0% | 114.1% | ₪216.8m | n/a | PE26.5x | n/a | 0% | ||
ARD | ₪54.35 | 5.5% | -8.6% | ₪1.3b | n/a | PE15.2x | n/a | 3.3% | ||
HIPR | ₪17.02 | 0.7% | 40.7% | ₪796.9m | n/a | PE12.7x | n/a | 2.2% | ||
INTR | ₪69.00 | -6.2% | n/a | ₪140.0m | n/a | PE15.2x | n/a | 0.7% |